Overview

Teriparatide Treatment in Patients With Inherited Osteoporosis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analyse efficacy of teriparatide treatment in patients with new forms of inherited low-turnover osteoporosis.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
Eli Lilly and Company
Treatments:
Teriparatide